Skip to main content

Table 1 The prevalence characteristics of three glucose group

From: Advanced glycation end products and diabetes and other metabolic indicators

  Normal Impaired glucose tolerance(IGT) DM χ2 value
Age
 < 65 541(82.80%) 63(9.60%) 49(7.50%) 20.11**
 ≥ 65 173(71.50%) 27(11.20%) 42(17.40%)  
Gender 5.23
 Male 378(77.50%) 59(12.10%) 51(10.50%)  
 Female 345(82.50%) 32(7.70%) 41(9.80%)  
BMI 12.20**
 Normal 402(83.60%) 41(8.50%) 38(7.90%)  
 Overweight 257(76.90%) 39(11.70%) 38(11.40%)  
 Obesity 64(71.10%) 10(11.10%) 16(17.80%)  
HDL
 Normal 669(80.00%) 85(10.20%) 82(9.80%) 1.51
 Abnormal 54(77.10%) 6(8.60%) 10(14.30%)  
UA 2.69
 Normal 542(80.70%) 61(9.10%) 69(10.30%)  
 Abnormal 181(77.40%) 30(12.80%) 23(9.80%)  
TC 2.28
 Normal 624(80.00%) 81(10.40%) 75(9.60%)  
 Abnormal 99(78.60%) 10(7.90%) 17(13.50%)  
TG 6.23*
 Normal 518(82.00%) 58(9.20%) 56(8.90%)  
 Abnormal 205(74.80%) 33(12.00%) 36(13.10%)  
SBP 27.72**
 Normal 577(83.40%) 64(9.20%) 51(7.40%)  
 Abnormal 143(68.40%) 27(12.90%) 39(18.70%)  
AGE 37.95**
 ≤ P25 193(84.60%) 23(10.10%) 12(5.30%)  
 P25–P50 191(84.90%) 23(10.20%) 11(4.90%)  
 P50–P75 177(77.60%) 27(11.80%) 24(10.50%)  
 > P75 162(72.00%) 18(8.00%) 45(20.00%)  
  1. *P < 0.05
  2. **P < 0.01